Lataa...

Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases

Phosphodiesterase type-5 (PDE-5) is an enzyme that catalyzes the hydrolytic degradation of cyclic GMP – an essential intracellular second messenger that modulates diverse biological processes in living cells. Three selective inhibitors of PDE-5 – sildenafil, vardenafil and tadalafil – have been succ...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kukreja, Rakesh C, Salloum, Fadi N, Das, Anindita, Koka, Saisudha, Ockaili, Ramzi A, Xi, Lei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Pulsus Group Inc 2011
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206106/
https://ncbi.nlm.nih.gov/pubmed/22131856
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!